Selected Topics in Stroke and Cerebrovascular Disease

This online course was developed from material delivered at the live course which occurs on Amelia Island, September 26-29, 2013. The live course addressed stroke, which is the 4th leading cause of death, killing over 133,000 people each year. Stroke also remains a leading cause of serious long-term disability in the United States.  Modifiable risk factors for stroke are common and include high blood pressure, high cholesterol, diabetes, and smoking.  Education about stroke risk factors leading to better management can significantly reduce the risk of stroke.  Awareness of acute therapies for stroke intervention such as tissue plasminogen activator (tPA) can significantly improve ischemic stroke morbidity and mortality. This online course will pull the top presentations from the live course and convert into an interactive online course.

Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mayo Clinic College of Medicine designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credits ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Commercial Support

This activity is supported in part by an educational grant from the following companies in accordance with ACCME Standards:

Grants

  • Codman
  • Genentech

Target Audience

This activity is appropriate for Physicians/surgeons of various specialties, allied health (nursing, nurse practioners, physician assistants, physical and occupational therapy, speech therapy).

 

Learning Objectives

Upon conclusion of this program, participants should be able to:

1.    Recognize the eligibility for intravenous TPA in acute ischemic stroke
2.    Identify modifiable stroke risk factors and interventions (e.g., blood pressure control)
3.    Recognize the signs and symptoms of stroke that prompt emergency evaluation and earlier treatment
4.    Evaluate the data and outcomes of clinical trials and the impact on treatment options for stroke patients

Participation in this Mayo course does not indicate or guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.


 

Course summary
Available credit: 
  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Attendance
Course opens: 
01/14/2015
Course expires: 
12/31/2016
Cost:
$75.00

Mayo Faculty

Maria I. Aguilar, M.D.
Kevin M. Barrett, M.D., MSc
Abba C. Zubair, M.D., Ph.D.
Robert D. Brown, M.D.
Bart M. Demaerschalk, M.D.
Giuseppe Lanzino, MD
Ben Brown, MD
Alejandro A. Rabinstein, M.D.
Rabih G. Tawk, M.D.

Disclosure

As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed.

Relevant financial relationship(s) with industry:

Name

Bart M. Demaerschalk, MD



 

Giuseppe Lanzino, MD

Nature of Relationship

Consultant

Consultant

Consultant

Grant/Research Support

Consultant

Company

Genentech

CellTrust

REACH

Calgary Scientific

ev3/Covidien

No relevant financial relationship(s) with industry:

Maria I. Aguilar, MD

Kevin M. Barret, MD, MSc

Robert D. Brown, Jr., MD

Benjamin L. Brown, MD

Alejandro A. Rabinsteain, MD

Rabih G. Tawk, MD

Abba C. Zubair, MD, PhD
 

References to off-label and/or investigational  usage(s) of pharmaceuticals or instruments in their presentation:

Name

Giuseppe Lanzino, MD

Manufacturer/Provider

St. Jude

Product/Device

Amplatzer Septal Occlusion Devices for PFO closure

Available Credit

  • 6.00 AMA PRA Category 1 Credit™
  • 6.00 Attendance

Price

Cost:
$75.00
Please login or register to take this course.